Daxor Insider Trades
NASDAQ: DXRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 7 · $18.97K
- Sales
- 0 · $0
- Shares bought / sold
- 31.29K / 0
- Net activity
- Net buying $18,970
Daxor insider activity
Over the last 12 months, Daxor insiders reported 11 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $18,970 and sold $0 worth of stock, for net insider buying of $18,970. The most recent filing shows Jefferies John (Chief Medical Officer) reporting a transaction in 2,451 shares on Aug 28, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DXR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
DXR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 28, 2026 | Jefferies JohnChief Medical Officer | Award | 2,451 | — | Form 4 |
| Jun 23, 2026 | Feldschuh Jonathan AdamChief Scientific Officer | Award | 25,000 | — | Form 4 |
| Jun 23, 2026 | Feldschuh Michael RichardChief Executive Officer | Award | 30,000 | — | Form 4 |
| Jun 23, 2026 | Michel Robert JChief Financial Officer | Award | 12,000 | — | Form 4 |
| Apr 8, 2026 | Feldschuh Michael RichardChief Executive Officer | Buy | 1,000 | $9.07K | Form 4 |
| Mar 31, 2026 | Michel Robert JChief Financial Officer | Buy | 1,000 | $9.90K | Form 4 |
| Mar 20, 2026 | Jefferies JohnChief Medical Officer | Buy | 2,285 | — | Form 4 |
| Mar 20, 2026 | Jefferies JohnChief Medical Officer | Buy | 3,656 | — | Form 4 |
| Dec 9, 2025 | Michel Robert JChief Financial Officer | Buy | 3,000 | — | Form 4 |
| Dec 9, 2025 | Feldschuh Jonathan AdamChief Scientific Officer | Buy | 18,000 | — | Form 4 |
| Nov 12, 2025 | Jefferies JohnChief Medical Officer | Buy | 2,344 | — | Form 4 |
| Apr 4, 2025 | Feldschuh Michael RichardChief Executive Officer | Buy | 2,063 | $16.28K | Form 4 |
| Mar 10, 2025 | Feldschuh Michael RichardChief Executive Officer | Buy | 3,360 | $25.80K | Form 4 |
| Mar 10, 2025 | Michel Robert JChief Financial Officer | Buy | 1,000 | $8.00K | Form 4 |
| Dec 6, 2024 | Feldschuh Michael RichardChief Executive Officer | Buy | 45,000 | — | Form 4 |
| Dec 6, 2024 | Feldschuh Jonathan AdamChief Scientific Officer | Buy | 32,000 | — | Form 4 |
| Mar 27, 2024 | Michel Robert JChief Financial Officer | Buy | 750 | $6.53K | Form 4 |
| Mar 26, 2024 | Feldschuh Michael RichardChief Executive Office | Buy | 1,000 | $8.13K | Form 4 |
| Mar 19, 2024 | Feldschuh Michael RichardChief Executive Officer | Buy | 647 | $5.27K | Form 4 |
| Mar 10, 2024 | Feldschuh Michael RichardChief Executive Officer | Buy | 1,492 | $11.52K | Form 4 |
| Mar 4, 2024 | Feuer EdwardDirector | Buy | 1,000 | $7.21K | Form 4 |
| Dec 6, 2023 | Michel Robert JChief Financial Officer | Buy | 120 | $930 | Form 4 |
| Dec 1, 2023 | Michel Robert JChief Financial Officer | Buy | 180 | $1.40K | Form 4 |
| Dec 1, 2023 | Feldschuh Michael RichardChief Executive Officer | Buy | 800 | $6.24K | Form 4 |
| Nov 24, 2023 | Michel Robert JChief Financial Officer | Buy | 500 | $3.97K | Form 4 |
| Nov 21, 2023 | Feldschuh Michael RichardCHIEF EXECUTIVE OFFICER | Award | 84 | $642.60 | Form 4 |
| Nov 10, 2023 | Feldschuh Michael RichardCHIEF EXECUTIVE OFFICER | Buy | 1,001 | $7.84K | Form 4 |
| Nov 9, 2023 | Feldschuh Michael RichardCHIEF EXECUTIVE OFFICER | Buy | 401 | $3.15K | Form 4 |
| Oct 31, 2023 | Michel Robert JChief Financial Officer | Award | 2,000 | — | Form 4 |
| Mar 27, 2023 | Michel Robert JChief Financial Officer | Buy | 4,750 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4